Literature DB >> 14990983

Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.

T L Kiss1, H Chang, A Daly, H A Messner, N Jamal, D Spaner, S Rubin, J H Lipton.   

Abstract

Pre transplant screening work-up of donors for allogeneic blood and marrow transplantation is essential in an effort to minimize risks to the recipient and protect the donor. At Princess Margaret Hospital, every potential donor is screened with a bone marrow aspirate. The case histories of three asymptomatic potential donors who presented within 1 year with normal complete blood counts, history and physical examination are presented. A 65-year-old male patient was diagnosed with smouldering multiple myeloma, a 72-year-old male patient with chronic lymphocytic leukemia and a 42-year-old male patient with myelodysplastic syndrome. Bone marrow examination led to the diagnosis in each one of these cases. Of note is that each of the potential donors was discovered to have the same disease as the transplant recipient. In vitro clonogenic hemopoietic progenitor assays were compared to those of 20 normal volunteers. Inferior growth of hemopoietic progenitor colonies in all three was noted. In conclusion, particularly in older donors and donors with potential for familial malignancies, more screening investigations including bone marrow aspiration may be reasonable to investigate for occult hematological malignancies prior to stem cell donation. Clonogenic assays can contribute to detect hemopoietic abnormalities pre transplant.

Entities:  

Mesh:

Year:  2004        PMID: 14990983     DOI: 10.1038/sj.bmt.1704430

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  Risks and mechanisms of oncological disease following stem cell transplantation.

Authors:  Sergey V Anisimov; Asuka Morizane; Ana S Correia
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

2.  A novel chromosomal abnormality, t(6;10)(q27;q22), found in a polycythemic potential donor for allogeneic hematopoietic stem cell transplantation.

Authors:  Hideki Mitsui; Norimitsu Saito; Atsushi Satake; Tsuyoshi Nakazawa; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 3.  Sixty as the new forty: considerations on older related stem cell donors.

Authors:  P Anderlini
Journal:  Bone Marrow Transplant       Date:  2016-08-08       Impact factor: 5.483

4.  Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities.

Authors:  Matthew P Tilson; Richard J Jones; Amy Sexauer; C A Griffin; Laura A Morsberger; Denise A S Batista; Donald Small; Kathleen H Burns; Christopher D Gocke; Milena Vuica-Ross; Michael J Borowitz; Amy S Duffield
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-13       Impact factor: 5.742

5.  Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.

Authors:  Matthew D Seftel; Michelle Kuxhausen; Linda Burns; Pintip Chitphakdithai; Dennis Confer; Deirdre Kiefer; Stephanie Lee; Brent Logan; Paul O'Donnell; Michael Pulsipher; Nirali N Shah; Galen Switzer; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-05       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.